Pharmacodynamic-Tolerability Relationships of Cholinesterase Inhibitors for Alzheimer's Disease

Author： Imbimbo B.P.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.5, 2001-01, pp. : 375-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors in Alzheimer's Disease: Are they Worth the Cost?

By Whitehouse P.J.  

CNS Drugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 167-173

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease: A Review with Methodological Considerations

By Wimo A.  

Drugs & Aging, Vol. 21, Iss. 5, 2004-01 ,pp. : 279-295

Adis International

Access to resources Recommend Favorite